Strategic Blueprint LLC Acquires 745 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Strategic Blueprint LLC increased its holdings in UnitedHealth Group by 18.9%, acquiring an additional 745 shares, resulting in a total of 4,681 shares valued at approximately $1,460,000.
• Several hedge funds have adjusted their positions in UnitedHealth Group, with Citizens National Bank Trust Department and Wealth Effects LLC also increasing their stakes significantly in recent quarters.
• Notable analysts have revised their price targets for UnitedHealth Group, with Mizuho raising its target from $300 to $430 while maintaining an "outperform" rating.

Strategic Blueprint LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,681 shares of the healthcare conglomerate's stock after acquiring an additional 745 shares during the quarter. Strategic Blueprint LLC's holdings in UnitedHealth Group were worth $1,460,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Citizens National Bank Trust Department increased its position in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after acquiring an additional 170 shares during the period. Caitlin John LLC increased its position in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares during the period. Triumph Capital Management purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $1,324,000. Wealth Effects LLC increased its position in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after buying an additional 591 shares during the period. Finally, Arlington Partners LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $2,229,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research report on Thursday, October 9th. Royal Bank Of Canada reduced their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Barclays upped their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Finally, The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a "buy" rating and a $406.00 price objective on the stock. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $385.13.

UnitedHealth Group Trading Up 0.6%

Shares of NYSE UNH opened at $362.78 on Friday. The firm's 50 day moving average price is $338.43 and its 200-day moving average price is $338.97. The company has a market cap of $328.56 billion, a PE ratio of 15.72, a P/E/G ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.